Study To Investigate The Effectiveness Of Pregabalin For Management Of Patients Undergoing Total Hip Replacement
Status:
Terminated
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is the investigate if pregabalin started a day before surgery and
continued for 14 days post-operatively can reduce post-operative pain, relieve pre- and
post-operative anxiety and sleep disturbances.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.